Simpson Thacher Represents The Blackstone Group and ReAble Therapeutics, Inc. in Connection with ReAble's $1.6 Billion Acquisition of DJO Incorporated
07.16.07
This is only gets display when printing
Simpson Thacher is representing The Blackstone Group and its portfolio company, ReAble Therapeutics, Inc., in ReAble's acquisition of DJO Incorporated. Under the terms of the deal, each holder of DJO common stock will receive $50.25 per share, representing a premium of approximately 25 percent over DJO's average closing share price for the 30 trading days ending July 13, 2007. The transaction is valued at approximately $1.6 billion.
DJO Incorporated (NYSE:DJO) is a global provider of products and services that promote musculoskeletal and vascular health. ReAble Therapeutics, Inc. is a diversified medical device company focused on rehabilitation, pain management, physical therapy and orthopedics. Simpson Thacher also represented Blackstone in its November 2006 acquisition of ReAble (then-known as Encore Medical).
The Simpson Thacher attorneys working on the deal are: Bill Dougherty, Joel Karansky and Richard Kim (M&A); Alden Millard and Brian Steinhardt (Credit); Gary Mandel and Jonathan Goldstein (Tax); Richard Fenyes (Capital Markets); Greg Grogan and Eric Sarabia (ERISA); Andrew Silverman (Real Estate); Lori Lesser and Brian McCloskey (Intellectual Property); Adeeb Fadil and Timothy Mulvihill (Environmental); Aimee Goldstein, Olivier Antoine and Tim Cornell (Litigation); summer associates Chang Won Choi and Ariana Cooper; and paralegal Kevin Johannsen.